unknown
Stage
About
Delphistem develops a stem cell-based therapy aimed at restoring natural insulin production in people with diabetes using a non-invasive, cost-effective, and scalable approach.
Explore Delphistem's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.